Monitoring progression of chronic cardiovascular conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, longitudinal project that collects physiologic data from adults with a range of cardiovascular conditions to document their natural history. Data collection uses wearable biosensor patches and scheduled data uploads, with participants required to understand consent and follow study instructions in English. People with recent severe cardiac events, end‑stage noncardiac illnesses, or allergy to the patch adhesive are excluded. The study is sponsored by Prolaio and enrolls participants who reside in the United States.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age and older
* Ability to understand study assessments and give informed consent to data collection
* Ability to comply with the study protocol
* Ability to understand and respond to instructions in English
* Has diagnosis of qualifying Cardiovascular Disease(s), including but not limited to: HF, AS, HCM, HTN, DCM, etc. Additional CVD may be included at discretion of the investigators.
* Resides in the United States

Exclusion Criteria:

* Allergy to adhesive used in biosensor patch
* Life-threatening disease process outside of area under study, such as actively treated cancer or being actively considered for organ pre-transplant (such as hepatic failure; end-stage renal disease).
* Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV
* \-- For participants who do not qualify due to this exclusion, and have not been hospitalized within 30 days of enrollment, they may reapply to enroll in the study
* Self-reported weight of 400 pounds or greater

Where it's running

• Prolaio
  Chicago, Illinois, United States Recruiting

Study contacts

• Study coordinator: Study Team OCORO Study
• Email: OCOROstudy@prolaio.com
• Phone: 1-855-869-9054

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise and nutrition support before and after TAVI for older adults with aortic stenosis

  This trial tests whether a personalized exercise program plus protein and iron supplements before and after a transcatheter valve replacement can help older adults with aortic stenosis recover better than standard care.

  Recruiting University Hospital of Ferrara · Ferrara, FE · NCT07895719

• Understanding aldosterone in hypertension among Kaiser Permanente members

  This is an observational program to see how aldosterone relates to high blood pressure in adults with hypertension, using data from Kaiser Permanente members in Northern California.

  Recruiting Kaiser Permanente · Oakland, California · NCT07780500

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

• Second infusion of FAP-targeted iCDC for end-stage dilated cardiomyopathy

  This study tests whether a second dose of FAP-targeted immunosuppressive CAR-DC therapy can safely improve heart function in adults with end-stage dilated cardiomyopathy who previously had a partial response.

  Recruiting Phase 1 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang / 浙江 · NCT07516288

• Beetroot extract effects on blood pressure and muscle oxygen during exercise in older women with high blood pressure

  This trial will test whether a beetroot supplement taken before exercise lowers blood pressure and improves muscle oxygen levels in women aged 60 to 70 with high blood pressure.

  Recruiting São Paulo State University · Bauru, São Paulo · NCT07444138

• Endocardial delivery of stem-cell derived heart cells to help severe heart failure

  This study tests endocardial delivery of HS-001 cell sheets made from iPSC-derived cardiomyocytes in adults with severe heart failure and reduced ejection fraction to see if it is safe and may improve heart function over 26 weeks.

  Recruiting at 5 sites Phase 1/2 Heartseed Inc. · Tsukuba, Ibaraki and 4 other locations · NCT07347197

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.